Universitätsklinik für Anästhesie und Intensivmedizin
Linz, Austria
NCT Number: NCT06870851
Viscoelastic testing is a highly recommended cornerstone of modern coagulation medicine, reducing transfusion needs. A disadvantage of viscoelastic tests is the impossibility of making a definitive statement about the platelet count.
Therefore, the aim of this retrospective observational study is, on the one hand, to predict the platelet count based on standard ROTEM parameters with the help of several machine learning methods and, on the other hand, to detect a low platelet count ( <100000 ml-1 and < 50000 ml-1).
This study is active but is not currently recruiting participants.
18 year–100 year
All sexes
Observational
Linz, Austria
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Obtained ROTEM analyses are the baseline at all four centres and patients will be included if platelets were determined concomitantly within three hours on the same day.
Several machine learning techniques for the prediction of the platelet concentration from ROTEM parameters (regression approach), namely linear regression, Random Forest, neural network, gradient boosting machine (GBM) and adaptive boosting (ADA) will be assessed. Describing the quality of these prediction models, the mean square error (MSE), the root of the mean of the square of errors(RMSE), the mean absolute error (MAE), and the root mean squared logarithmic error (RMSLE), and the coefficient of determination (R2) will be used.
Kepler University Hospital
Other
Machine Learning Based Prediction of Platelet Concentration From ROTEM Measurements
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05396157
Bleeding Hemorrhage, Blood Platelet Disorders
Toronto, Ontario, Canada
View Trial DetailsNCT02912208
Blood Platelet Disorders, Bone Marrow Diseases
Amiens, France
View Trial DetailsNCT02858323
Blood Platelet Disorders, Cytopenia
Bethesda, Maryland, United States
View Trial DetailsNCT07696767
Blood Platelet Disorders, Cytopenia
View Trial Details